GROSSMAN ADAM S (President and CEO) reported 1 transaction at ADMA BIOLOGICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/23/2026ACC: 0001140361-26-006461
DirectorOfficer· President and CEO
Since Feb 2026
-24.79K
Net shares
Net seller
$404.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
24.79K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.79K
Price / share
$16.32
Trade value
$404.62K
% of position
1.1%
2/19/2026
2.28M→2.26M
Total
Net shares
−24.79K
Net value
-$404.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | F · Tax Withholding | −24.79K | $16.32 | $404.62K | 1.1% | 2.28M | 2.26M |
| Total | −24.79K | -$404.62K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.14M
Common Stock
IndirectShares owned580.96K
Total
1.72M indirect1.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.14M | Indirect |
| Common Stock | 580.96K | Indirect |
| Total | 1.72M | 1.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported